Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses [C01] | |||||
Brands: Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FLUCONAZOLE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: FCA-CH-88-002 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |